logo
About Contact

AI Innovations Propel Drug Development: Collaborations and Investments Shape the Future of Pharmaceutical Research

AI News

AI Innovations Propel Drug Development: Collaborations and Investments Shape the Future of Pharmaceutical Research

Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

Economic Times

Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's

Phylo Partners With Bayer on Biomni Lab AI Agents for Drug Research

Unite.AI

Phylo Partners With Bayer on Biomni Lab AI Agents for Drug Research

Phylo, Inc. announced on October 22, 2026, a partnership with Bayer to deploy Biomni Lab, Phylo's agentic AI platform, to accelerate scientific research and evaluation, with Bayer scientists...

Warp Sciences Emerges From Stealth With $215M for AI-Powered Chemistry Labs

Unite.AI

Warp Sciences Emerges From Stealth With $215M for AI-Powered Chemistry Labs

Designing a promising molecule is only the beginning of drug research. Someone still has to make it, test it, and turn the results into a better next experiment. Warp Sciences is betting that this...

OpenAI vs Google DeepMind: How the AI drug discovery race is shaping up

Digit

OpenAI vs Google DeepMind: How the AI drug discovery race is shaping up

Forget the model wars for now. Meanwhile, there is an AI battle taking place regarding new drug development. Google’s subsidiary, DeepMind, has been developing protein folding for several years...

Coverage dates

First reported:

First saved on ClustZ:

Coverage updated:

We use cookies to improve your experience and analyze site traffic. By clicking "Accept", you agree to our use of cookies. See our Privacy Policy.